Primary handling editor: Christoph Schmitt
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone that specifically targets fat metabolism without systemic growth hormone effects
The most common adverse events are gastrointestinal: nausea (occurring in 12-33% of subjects depending on dose), diarrhea, constipation, and decreased appetite
Factors That Influence Your Personal Timeline The timeline above is typical, but several factors shape how fast you personally see results
Similarly, clinicians, policy-makers, and people with obesity may find the mean weight loss of a treatment of little practical or planning value, while the proportions of people achieving categorical weight loss of 5, 10, and 15% might be more relevant to inform real-world clinical practice
This leads us to the million-dollar question: Why is it so important for 5-Amino 1MQ to inhibit NNMT